Diclegis Tablet, Delayed Release
Product Images NDC 55494-100

4 FDA label images from Duchesnay Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclegis (NDC 55494-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Duchesnay Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)
DICLEGIS delayed-release tablets label shows 10 mg doxylamine succinate and 10 mg pyridoxine hydrochloride per tablet. The label states directions for use, a warning to swallow tablets whole, and storage instructions. It indicates a package size of 100 tablets, distributed by Duchesnay USA, Inc., with barcode and patent information included.*
FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Bottle Label – Inside Cover (Bottle Label Inside)
DICLEGIS 10 mg/10 mg delayed-release tablets carton label for oral use, containing doxylamine succinate and pyridoxine hydrochloride. The label includes storage conditions, dispensing instructions, warnings not to crush or chew tablets, and manufacturer details Duchesnay USA, Inc. It indicates a package of 100 tablets with NDC 55494-100-10. Kosher certification symbols are also present.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure diagram showing the molecular structures of doxylamine succinate and pyridoxine hydrochloride, the active ingredients in DICLEGIS delayed-release tablets.*
FDA Label Image

Structure-2 (Structure 2)

Structure-2 (Structure 2)
Chemical structure of pyridoxine hydrochloride, an active ingredient in DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.